Literature DB >> 28035019

Integration of Population-Level Genotype Data with Functional Annotation Reveals Over-Representation of Long Noncoding RNAs at Ovarian Cancer Susceptibility Loci.

Brett M Reid1, Jennifer B Permuth1, Y Ann Chen1, Jamie K Teer1, Alvaro N A Monteiro1, Zhihua Chen1, Jonathan Tyrer2, Andrew Berchuck, Georgia Chenevix-Trench, Jennifer A Doherty3, Ellen L Goode4, Edwin S Iverson5, Kate Lawrenson6, Celeste L Pearce7, Paul D Pharoah2, Catherine M Phelan1, Susan J Ramus8, Mary Anne Rossing9, Joellen M Schildkraut10, Jin Q Cheng1, Simon A Gayther6, Thomas A Sellers.   

Abstract

BACKGROUND: Genome-wide association studies (GWAS) have identified multiple loci associated with epithelial ovarian cancer (EOC) susceptibility, but further progress requires integration of epidemiology and biology to illuminate true risk loci below genome-wide significance levels (P < 5 × 10-8). Most risk SNPs lie within non-protein-encoding regions, and we hypothesize that long noncoding RNA (lncRNA) genes are enriched at EOC risk regions and represent biologically relevant functional targets.
METHODS: Using imputed GWAS data from about 18,000 invasive EOC cases and 34,000 controls of European ancestry, the GENCODE (v19) lncRNA database was used to annotate SNPs from 13,442 lncRNAs for permutation-based enrichment analysis. Tumor expression quantitative trait locus (eQTL) analysis was performed for sub-genome-wide regions (1 × 10-5 > P > 5 × 10-8) overlapping lncRNAs.
RESULTS: Of 5,294 EOC-associated SNPs (P < 1.0 × 10-5), 1,464 (28%) mapped within 53 unique lncRNAs and an additional 3,484 (66%) SNPs were correlated (r2 > 0.2) with SNPs within 115 lncRNAs. EOC-associated SNPs comprised 130 independent regions, of which 72 (55%) overlapped with lncRNAs, representing a significant enrichment (P = 5.0 × 10-4) that was more pronounced among a subset of 5,401 lncRNAs with active epigenetic regulation in normal ovarian tissue. EOC-associated lncRNAs and their putative promoters and transcription factors were enriched for biologically relevant pathways and eQTL analysis identified five novel putative risk regions with allele-specific effects on lncRNA gene expression.
CONCLUSIONS: lncRNAs are significantly enriched at EOC risk regions, suggesting a mechanistic role for lncRNAs in driving predisposition to EOC. IMPACT: lncRNAs represent key candidates for integrative epidemiologic and functional studies. Further research on their biologic role in ovarian cancer is indicated. Cancer Epidemiol Biomarkers Prev; 26(1); 116-25. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 28035019      PMCID: PMC5312656          DOI: 10.1158/1055-9965.EPI-16-0341

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.090


  71 in total

1.  Long, abundantly expressed non-coding transcripts are altered in cancer.

Authors:  Damon S Perez; Tiffany R Hoage; Jay R Pritchett; Allison L Ducharme-Smith; Meredith L Halling; Sree C Ganapathiraju; Paul S Streng; David I Smith
Journal:  Hum Mol Genet       Date:  2007-11-15       Impact factor: 6.150

2.  A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression.

Authors:  Kevin C Wang; Yul W Yang; Bo Liu; Amartya Sanyal; Ryan Corces-Zimmerman; Yong Chen; Bryan R Lajoie; Angeline Protacio; Ryan A Flynn; Rajnish A Gupta; Joanna Wysocka; Ming Lei; Job Dekker; Jill A Helms; Howard Y Chang
Journal:  Nature       Date:  2011-03-20       Impact factor: 49.962

3.  Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Authors:  Aravind Subramanian; Pablo Tamayo; Vamsi K Mootha; Sayan Mukherjee; Benjamin L Ebert; Michael A Gillette; Amanda Paulovich; Scott L Pomeroy; Todd R Golub; Eric S Lander; Jill P Mesirov
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-30       Impact factor: 11.205

4.  LSINCT5 is over expressed in breast and ovarian cancer and affects cellular proliferation.

Authors:  Jessica M Silva; Nicole J Boczek; Michael W Berres; Xinghong Ma; David I Smith
Journal:  RNA Biol       Date:  2011-05-01       Impact factor: 4.652

Review 5.  Role of genetic polymorphisms and ovarian cancer susceptibility.

Authors:  Peter A Fasching; Simon Gayther; Leigh Pearce; Joellen M Schildkraut; Ellen Goode; Falk Thiel; Georgia Chenevix-Trench; Jenny Chang-Claude; Shan Wang-Gohrke; Susan Ramus; Paul Pharoah; Andrew Berchuck
Journal:  Mol Oncol       Date:  2009-02-04       Impact factor: 6.603

Review 6.  Ovarian cancer and polymorphisms in the androgen and progesterone receptor genes: a HuGE review.

Authors:  Francesmary Modugno
Journal:  Am J Epidemiol       Date:  2004-02-15       Impact factor: 4.897

7.  The polymorphism rs944289 predisposes to papillary thyroid carcinoma through a large intergenic noncoding RNA gene of tumor suppressor type.

Authors:  Jaroslaw Jendrzejewski; Huiling He; Hanna S Radomska; Wei Li; Jerneja Tomsic; Sandya Liyanarachchi; Ramana V Davuluri; Rebecca Nagy; Albert de la Chapelle
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-14       Impact factor: 11.205

8.  Enrichment of putative PAX8 target genes at serous epithelial ovarian cancer susceptibility loci.

Authors:  Siddhartha P Kar; Emily Adler; Jonathan Tyrer; Dennis Hazelett; Hoda Anton-Culver; Elisa V Bandera; Matthias W Beckmann; Andrew Berchuck; Natalia Bogdanova; Louise Brinton; Ralf Butzow; Ian Campbell; Karen Carty; Jenny Chang-Claude; Linda S Cook; Daniel W Cramer; Julie M Cunningham; Agnieszka Dansonka-Mieszkowska; Jennifer Anne Doherty; Thilo Dörk; Matthias Dürst; Diana Eccles; Peter A Fasching; James Flanagan; Aleksandra Gentry-Maharaj; Rosalind Glasspool; Ellen L Goode; Marc T Goodman; Jacek Gronwald; Florian Heitz; Michelle A T Hildebrandt; Estrid Høgdall; Claus K Høgdall; David G Huntsman; Allan Jensen; Beth Y Karlan; Linda E Kelemen; Lambertus A Kiemeney; Susanne K Kjaer; Jolanta Kupryjanczyk; Diether Lambrechts; Douglas A Levine; Qiyuan Li; Jolanta Lissowska; Karen H Lu; Jan Lubiński; Leon F A G Massuger; Valerie McGuire; Iain McNeish; Usha Menon; Francesmary Modugno; Alvaro N Monteiro; Kirsten B Moysich; Roberta B Ness; Heli Nevanlinna; James Paul; Celeste L Pearce; Tanja Pejovic; Jennifer B Permuth; Catherine Phelan; Malcolm C Pike; Elizabeth M Poole; Susan J Ramus; Harvey A Risch; Mary Anne Rossing; Helga B Salvesen; Joellen M Schildkraut; Thomas A Sellers; Mark Sherman; Nadeem Siddiqui; Weiva Sieh; Honglin Song; Melissa Southey; Kathryn L Terry; Shelley S Tworoger; Christine Walsh; Nicolas Wentzensen; Alice S Whittemore; Anna H Wu; Hannah Yang; Wei Zheng; Argyrios Ziogas; Matthew L Freedman; Simon A Gayther; Paul D P Pharoah; Kate Lawrenson
Journal:  Br J Cancer       Date:  2017-01-19       Impact factor: 7.640

9.  Integrative analysis of 111 reference human epigenomes.

Authors:  Anshul Kundaje; Wouter Meuleman; Jason Ernst; Misha Bilenky; Angela Yen; Alireza Heravi-Moussavi; Pouya Kheradpour; Zhizhuo Zhang; Jianrong Wang; Michael J Ziller; Viren Amin; John W Whitaker; Matthew D Schultz; Lucas D Ward; Abhishek Sarkar; Gerald Quon; Richard S Sandstrom; Matthew L Eaton; Yi-Chieh Wu; Andreas R Pfenning; Xinchen Wang; Melina Claussnitzer; Yaping Liu; Cristian Coarfa; R Alan Harris; Noam Shoresh; Charles B Epstein; Elizabeta Gjoneska; Danny Leung; Wei Xie; R David Hawkins; Ryan Lister; Chibo Hong; Philippe Gascard; Andrew J Mungall; Richard Moore; Eric Chuah; Angela Tam; Theresa K Canfield; R Scott Hansen; Rajinder Kaul; Peter J Sabo; Mukul S Bansal; Annaick Carles; Jesse R Dixon; Kai-How Farh; Soheil Feizi; Rosa Karlic; Ah-Ram Kim; Ashwinikumar Kulkarni; Daofeng Li; Rebecca Lowdon; GiNell Elliott; Tim R Mercer; Shane J Neph; Vitor Onuchic; Paz Polak; Nisha Rajagopal; Pradipta Ray; Richard C Sallari; Kyle T Siebenthall; Nicholas A Sinnott-Armstrong; Michael Stevens; Robert E Thurman; Jie Wu; Bo Zhang; Xin Zhou; Arthur E Beaudet; Laurie A Boyer; Philip L De Jager; Peggy J Farnham; Susan J Fisher; David Haussler; Steven J M Jones; Wei Li; Marco A Marra; Michael T McManus; Shamil Sunyaev; James A Thomson; Thea D Tlsty; Li-Huei Tsai; Wei Wang; Robert A Waterland; Michael Q Zhang; Lisa H Chadwick; Bradley E Bernstein; Joseph F Costello; Joseph R Ecker; Martin Hirst; Alexander Meissner; Aleksandar Milosavljevic; Bing Ren; John A Stamatoyannopoulos; Ting Wang; Manolis Kellis
Journal:  Nature       Date:  2015-02-19       Impact factor: 69.504

10.  Inhibition of the JAK2/STAT3 pathway in ovarian cancer results in the loss of cancer stem cell-like characteristics and a reduced tumor burden.

Authors:  Khalid Abubaker; Rodney B Luwor; Hongjian Zhu; Orla McNally; Michael A Quinn; Christopher J Burns; Erik W Thompson; Jock K Findlay; Nuzhat Ahmed
Journal:  BMC Cancer       Date:  2014-05-06       Impact factor: 4.430

View more
  2 in total

Review 1.  Toward More Comprehensive Homologous Recombination Deficiency Assays in Ovarian Cancer, Part 1: Technical Considerations.

Authors:  Stanislas Quesada; Michel Fabbro; Jérôme Solassol
Journal:  Cancers (Basel)       Date:  2022-02-23       Impact factor: 6.639

2.  An integrative functional genomics framework for effective identification of novel regulatory variants in genome-phenome studies.

Authors:  Junfei Zhao; Feixiong Cheng; Peilin Jia; Nancy Cox; Joshua C Denny; Zhongming Zhao
Journal:  Genome Med       Date:  2018-01-29       Impact factor: 11.117

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.